The Trendlines Group Trendletter May 2018
… Our most successful AgriVest … Q1 2018 results … Omeq Med on Exit Valley … U.S. patent for Arcuro Medical … Hargol a SEAL winner … Conferences and more conferences …
Trendlines issued its Q1 2018 results:
Omeq Medical started a fund-raising campaign on Exit Valley.
These medical companies are now funding: Ceretrieve, CorAlert, LapSpace Medical, liberDi, ProArc Medical, ZygoFix.
These agtech companies are now funding: AquiNovo, EdenShield, MiRobot, Valentis, ViAqua Therapeutics.
- Chairman and CEO Todd Dollinger is a panelist at US IPOs Revealed: A Preview For Israeli Life Science Companies, 3 June, Tel Aviv.
- Arcuro Medical, BioFishency, and Hargol FoodTech will present — and Todd Dollinger is a panelist — at the GoforIsrael China-Israel Investment Conference, Foshan, China, 31 May.
Watch the interview with Hargol FoodTech COO Ben Friedman at The Future of Everything Festival, 8-10 May, New York.
Our 13th year at Biomed: Israel’s Chief Scientist, Ministry of Economy and Industry, and Chairman of Israel Innovation Authority Ami Appelbaum, PhD (2nd from right) joins Yosi Hazan, Todd Dollinger, and Steve Rhodes at the Trendlines’ booth, 17th MIXiii-Biomed, 15-17 May, Tel Aviv.
Trendlines Agtech VP Bus. Dev. Sarai Kemp presents the incubator model at AgriTech, 9 May, Tel Aviv.
Trendlines Incubators Israel CEO Nitza Kardish presents to delegates from Qinhuai, China, at the Art & FoodTech Conference, 2 May, Akko, Israel. Agtech portfolio companies Hargol and AlgaHealth also presented.
Trendlines Medical VP Bus. Dev. Barak Singer takes time out at The MedTech Strategist conference, 17-19 April, Dublin.